Application 065230

Type
ANDA
Sponsor
HOSPIRA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CEFTRIAXONECEFTRIAXONE SODIUMINJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 250MG BASE/VIALNoNo
002CEFTRIAXONECEFTRIAXONE SODIUMINJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 500MG BASE/VIALNoNo
003CEFTRIAXONECEFTRIAXONE SODIUMINJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 1GM BASE/VIALNoNo
004CEFTRIAXONECEFTRIAXONE SODIUMINJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 2GM BASE/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
21695-202Ceftriaxone SodiumCeftriaxone SodiumRebel Distributors CorpANDACurrent
21695-352Ceftriaxone SodiumCeftriaxone SodiumRebel Distributors CorpANDACurrent
50090-0943CeftriaxoneCeftriaxoneA-S Medication SolutionsANDACurrent
60505-0750CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
60505-0750CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
60505-0750CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
60505-0751CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
60505-0751CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
60505-0751CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
60505-0752CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
60505-0752CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
60505-0752CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
60505-0753CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
60505-0753CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
60505-0753CeftriaxoneCeftriaxoneApotex CorporationANDACurrent
70518-0601CeftriaxoneCeftriaxoneREMEDYREPACK INC.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
23740ORIG2008-09-19